Literature DB >> 9458112

HLA class I and class II allele distribution in the Bubi population from the island of Bioko (Equatorial Guinea).

R de Pablo1, J M García-Pacheco, C Vilches, M E Moreno, L Sanz, M C Rementería, S Puente, M Kreisler.   

Abstract

We determined the HLA frequency distribution in a sample of 100 Bubi individuals born on the island of Bioko (Equatorial Guinea). HLA-A, -B and -C typing was performed by serology and PCR-SSP. DRB1/3/4/5, DQB1 and DQA1 alleles were determined by PCR-SSOP. The HLA allele distribution of this population group resembles those found in other Bantu-speaking groups; however, the higher frequency of A30, A32, B44, DRB1*1301 in the Bubi with respect to other Bantu groups and the absence of DR4 deserve special mention. The cloning and sequencing of class I and II genes in this population allowed the description of five new allelic variants: B*4407, Cw*0706, Cw*1801, Cw*1802 and DQB1*0612 and five confirmatory sequences: B*3910, B*5703, B*8101, Cw*1203 and Cw*1701. The following new HLA-C,B haplotypes have been found in Bubi: Cw*08-B*57, Cw*18-B*57, Cw*0302-B*53, Cw*07-B*53 and Cw*1601-B*63. The most frequent seven-locus haplotype is: A*30-Cw*17-B*42-DRB1*1102-DRB3*0202-DQA1*05-DQB1 *0301. In terms of genetic distance, the Bubi are closer to other Bantu groups than to West African populations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9458112     DOI: 10.1111/j.1399-0039.1997.tb02917.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  HLA in Jaidukama: an Amerindian secluded Colombian population with new haplotypes and Asian and Pacific-shared alleles.

Authors:  J Martinez-Laso; F Montoya; C Areces; J Moscoso; C Silvera; D Rey; C Parga-Lozano; P Gomez-Prieto; M Enriquez de Salamanca; A Arnaiz-Villena
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

2.  Human leukocyte antigen class I haplotypes of human immunodeficiency virus-1-infected persons on Likoma Island, Malawi.

Authors:  Otto O Yang; Martha J Lewis; Elaine F Reed; David W Gjertson; Linda Kalilani-Phiri; James Mkandawire; Stéphane Helleringer; Hans-Peter Kohler
Journal:  Hum Immunol       Date:  2011-05-24       Impact factor: 2.850

3.  Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Authors:  S J Mack; P Cano; J A Hollenbach; J He; C K Hurley; D Middleton; M E Moraes; S E Pereira; J H Kempenich; E F Reed; M Setterholm; A G Smith; M G Tilanus; M Torres; M D Varney; C E M Voorter; G F Fischer; K Fleischhauer; D Goodridge; W Klitz; A-M Little; M Maiers; S G E Marsh; C R Müller; H Noreen; E H Rozemuller; A Sanchez-Mazas; D Senitzer; E Trachtenberg; Marcelo Fernandez-Vina
Journal:  Tissue Antigens       Date:  2013-04

4.  Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential.

Authors:  Kara A Moser; Elliott F Drábek; Ankit Dwivedi; Emily M Stucke; Jonathan Crabtree; Antoine Dara; Zalak Shah; Matthew Adams; Tao Li; Priscila T Rodrigues; Sergey Koren; Adam M Phillippy; James B Munro; Amed Ouattara; Benjamin C Sparklin; Julie C Dunning Hotopp; Kirsten E Lyke; Lisa Sadzewicz; Luke J Tallon; Michele D Spring; Krisada Jongsakul; Chanthap Lon; David L Saunders; Marcelo U Ferreira; Myaing M Nyunt; Miriam K Laufer; Mark A Travassos; Robert W Sauerwein; Shannon Takala-Harrison; Claire M Fraser; B Kim Lee Sim; Stephen L Hoffman; Christopher V Plowe; Joana C Silva
Journal:  Genome Med       Date:  2020-01-08       Impact factor: 11.117

5.  HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations.

Authors:  Joaquín Zúñiga; Neng Yu; Rodrigo Barquera; Sharon Alosco; Marina Ohashi; Tatiana Lebedeva; Víctor Acuña-Alonzo; María Yunis; Julio Granados-Montiel; Alfredo Cruz-Lagunas; Gilberto Vargas-Alarcón; Tatiana S Rodríguez-Reyna; Marcelo Fernandez-Viña; Julio Granados; Edmond J Yunis
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.